VTAK Valuation

Catheter Precision Inc

Add to Watchlist

Advanced Chart

0.224

-0.008(-3.448%)1D

Overview
Forecast
Valuation
Earnings

VTAK Relative Valuation

VTAK's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, VTAK is overvalued; if below, it's undervalued.

Historical Valuation

Catheter Precision Inc (VTAK) is now in the Fair zone, suggesting that its current forward PS ratio of 0.77 is considered Fairly compared with the five-year average of -0.30. The fair price of Catheter Precision Inc (VTAK) is between 0.04 to 0.29 according to relative valuation methord.

Relative Value

Fair Zone

0.04-0.29

Current Price：0.23

Fair

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

0.26

P/B

Median3y

0.20

Median5y

0.20

-328.49

FCF Yield

Median3y

-452.43

Median5y

-452.43

Competitors Valuation Multiple

The average P/S ratio for VTAK's competitors is 0.53, providing a benchmark for relative valuation. Catheter Precision Inc Corp (VTAK) exhibits a P/S ratio of 0.77, which is 47.45% above the industry average. Given its robust revenue growth of 74.39%, this premium appears sustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

VTAK.A

Catheter Precision Inc

0.77

Average P/S: 0.53

74.39%